
    
      Wilson disease is an autosomal recessive disorder with copper metabolism. In Japan, the
      standard treatment is the use of copper chelating agents, such as D-penicillamine and
      trientine. In this study, we investigate efficacy on zinc acetate in Japanese patients with
      Wilson disease.
    
  